ORLANDO, Fla., Nov 15 (Reuters) - Heart attack patients in need of emergency procedures were less likely to suffer further serious cardiovascular events, including death, when given AstraZeneca's ...

WASHINGTON — Federal health officials said today a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart ...

BARCELONA (Reuters) - AstraZeneca's new pill Brilinta for preventing heart attacks works better than Plavix, the world's second biggest selling drug, without increasing the amount of life-threatening ...

Stent patients who take the blood thinner Plavix along with certain heartburn drugs may face a greater risk of heart attack, stroke and other dangerous events, according to a study released Tuesday.

Plavix is also given to those who have unstable angina or peripheral artery disease. Using Plavix in combination with aspirin may be more effective in preventing another heart attack, but this will ...

To the surprise of medical researchers, a major new study has found no benefit -- and perhaps even some harm -- from adding the anti-clotting drug Plavix to aspirin in an attempt to prevent heart ...

Sanofi-Aventis and Bristol-Myers Squibb Co. are facing generic competition in the U.S. for their top-selling Plavix blood-thinning pill five years earlier than planned. Apotex Inc., a closely held ...

> Bristol-Myers Squibb says that it expects Apotex to quickly begin delivering a generic version of its blockbuster anti-blood clotting drug Plavix. Apotex had agreed to delay rolling out a generic ...

Bristol faces a setback in the plavix litigation. Eli Lilly has trouble with Jardiance. Bellerophon gets FDA approval for COVID-19. Looking for more stock ideas like this one? Get them exclusively at ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Advertising brand-name prescription medications directly to patients is ...

Texas Attorney General Ken Paxton claims that for decades the drugmakers failed to disclose that the medication is less effective in some minority patients, but the companies say the lawsuit is "stale ...

LOS ANGELES Extreme complications from Type 1 diabetes and renal failure put 55-year-old Danny Parr in the hospital. But medical exams revealed he also has significant coronary artery disease, so he's ...